Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy: a systematic review and meta-analysis
Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use
When in doubt, contacting a pharmacist or healthcare provider is the safest option
The stopper will develop scar tissue (core formation) after 1015 needle insertions, making penetration harder and increasing the risk of rubber fragments entering the solution
Reconstitute with sterile bacteriostatic water under sterile conditions
GLP-1 also inhibits glucagon secretion when glucose levels are high, which prevents unnecessary sugar release into your bloodstream